 ZSCAN1 autoantibodies are associated with pediatric paraneoplastic ROHHAD Annals of Neurology, 2022
|
 Pneumonia surveillance with culture-independent metatranscriptomics in HIV-positive adults in Uganda: a cross-sectional study The Lancet, 2022
|
 Genome-Wide Knockout Screen Identifies Human Sialomucin CD164 as an Essential Entry Factor for Lymphocytic Choriomeningitis Virus American Society for Microbiology, 2022
|
 Autoantibody discovery across monogenic, acquired, and COVID19-associated autoimmunity with scalable PhIP-seq BiorRxiv, 2022
|
 Prolonged silent carriage, genomic virulence potential and transmission between staff and patients characterize a neonatal intensive care unit (NICU) outbreak of methicillin-resistant Staphylococcus aureus (MRSA) Cambridge University Press, 2022
|
 Using genomic epidemiology of SARS-CoV-2 to support contact tracing and public health surveillance in rural Humboldt County, California BMC Public Health, 2022
|
 Discovering disease-causing pathogens in resource-scarce Southeast Asia using a global metagenomic pathogen monitoring system PNAS, 2022
|
|  Scientists at Chan Zuckerberg (CZ) Biohub, Mayo Clinic and University of California, San Francisco (UCSF), have discovered an autoimmune disease that appears to affect men with testicular cancer. A postdoctoral fellow in the DeRisi lab, Caleigh Mandel-Brehm, led the study together with a clinical fellow at the Mayo Clinic, Divyanshu Dubey. Using a combination of customized programmable phage display, immunohistochemical staining, and other techniques, antibodies to the protein Kelch-like Protein 11 (KLHL11) was identified as a highly specific marker of a new paraneoplastic autoimmune syndrome associated with seminoma in men. Click Here for the Full Press Release |
|
